Advertisement
Advertisement

IDYA

IDYA logo

IDEAYA Biosciences, Inc. Common Stock

21.75
USD
+0.02
+0.09%
Feb 21, 16:00 UTC -5
Closed
exchange

After-Market

21.625

-0.13
-0.57%

IDEAYA Biosciences, Inc. Common Stock Profile

About

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.

Info & Links

CEO

Yujiro Hata

Headquarters

5000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.ideayabio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

8

Employees

131

IDEAYA Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.89B

Enterprise Value

1.81B

Enterprise Value/EBITDA(ttm)

-5.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

77.34

Price to Book(mrq)

1.69

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-26.74%

Return on Invested Capital(ttm)

-26.59%

Return on Assets(ttm)

-25.54%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-353.37M

Net Income Available to Common(ttm)

-274.48M

Diluted EPS(ttm)

-3.30

Share Statistics

Beta (5Y Monthly)

0.82

52-Week Change

-50.58%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

87.54M

Dividend Yield

0.00%

Float4

83.41M

% Held by Insiders

3.50%

% Held by Institutions

98.29%

Balance Sheet

Total Cash(mrq)

676.32M

Total Cash Per Share(mrq)

7.73

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.97%

Quick Ratio(mrq)

22.93%

Book Value Per Share(mrq)

12.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.03

Free Cash Flow(ytd)

-251.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement